MolNFT v1 · #72417 · protein
Crystal structure of blac-E166A covalently bound with amoxicillin
3N7W · Beta-lactamase: “Crystal structure of blac-E166A covalently bound with amoxicillin”. X-ray diffraction, 2 ligands (AXL, PO4), 1 pocket (best druggability 0.46). MolNFT v1 #72417 on GenesisL1: 3D structure, binding sites and pockets…
- PDB
- 3N7W
- Type
- protein
- Length
- 265 residues
- Chains
- 1
- Method
- x-ray diffraction
- Collection
- MolNFT v1 / PDB
- Contract
- 0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
- Owner
- 0x3396CDB397284571d12822B4ae1189a8E22AAAAA
- Molecule
- Beta-lactamase
- EC
- 3.5.2.6
- UniProt
- P0C5C1
- Ligands
- AXL, PO4
- Pockets
- 1 · best druggability 0.46
Structure
x-ray diffraction · 1 distinct chain · 45% helix, 17% strand (DSSP).
| Chain | Molecule | Type | Residues | Secondary structure | UniProt |
|---|---|---|---|---|---|
| A | Beta-lactamase (EC 3.5.2.6) | protein | 265 | 45% helix, 17% strand | P0C5C1 |
Ligands and binding sites
- AXL · 2-{1-[2-amino-2-(4-hydroxy-phenyl)-acetylamino]-2-oxo-ethyl}-5,5-dimethyl-thiazolidine-4-carboxylic acid · ligand · chains A
- PO4 · Phosphate ion · ion · 2 copies · chains A
Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.
Pockets
1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.
| Volume (ų) | Druggability | Buriedness | Lining residues | Inside | |
|---|---|---|---|---|---|
| 1 | 117 | 0.46 | 0.79 | 25 | AXL, PO4 |
Modifications
Observed in the structure: 1 covalent (covalent ligand).
Compared structures
- 3N7W · Crystal Structure of BlaC-E166A covalently bound with Amoxicillin · the same entry in another collection · chain A against A, TM-score 1.00
Analyse
- Open in the research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides and crosslinks on the 3D structure
- Every structure of UniProt P0C5C1
- Elsewhere: RCSB PDB 3N7W · PDBe 3N7W · UniProt P0C5C1
GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.